In this episode, YS Chi talks to Rhett Alden who joined Elsevier with “the idea, the expectation, that we’re really going to do something significant in the healthcare space to improve patients’ lives”. 

YS asks Rhett how it was possible to make such quick progress with the Covid vaccines, how to continue the push for more open access to information and how to build trust. Rhett shares his insights on all the possibilities that come with bringing different large data sets together to better understand patients, the exciting developments in oncology and the latest tools that are helping doctors find the best cancer treatments.

Rhett Alden is the chief technology officer for health and commercial markets at Elsevier.

This podcast is brought to you by RELX.